Arito M, Tsutiya A, Sato M, Omoteyama K, Sato T, Motonaga Y
BMC Mol Cell Biol. 2024; 25(1):24.
PMID: 39455917
PMC: 11515419.
DOI: 10.1186/s12860-024-00521-9.
Liu B, Zhang S, Sun L, Huang L, Zhang R, Liu Z
Int J Mol Sci. 2023; 24(17).
PMID: 37686162
PMC: 10487641.
DOI: 10.3390/ijms241713356.
Xiang D, Liu J, Zhong Z, Xiong Y, Kong H, Yu H
Curr Med Sci. 2023; 43(3):456-468.
PMID: 37115401
DOI: 10.1007/s11596-023-2734-5.
Kumar M, Bansal N
Mol Neurobiol. 2021; 59(1):354-385.
PMID: 34699027
DOI: 10.1007/s12035-021-02611-7.
Jiang X, He M, Bai J, Chan C, Wong A
Front Endocrinol (Lausanne). 2020; 11:20.
PMID: 32082258
PMC: 7003395.
DOI: 10.3389/fendo.2020.00020.
Brief Report: Cell Cycle Dynamics of Human Pluripotent Stem Cells Primed for Differentiation.
Shcherbina A, Li J, Narayanan C, Greenleaf W, Kundaje A, Chetty S
Stem Cells. 2019; 37(9):1151-1157.
PMID: 31135093
PMC: 6711778.
DOI: 10.1002/stem.3041.
Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer.
Harada K, Ferdous T, Ueyama Y
Jpn Dent Sci Rev. 2017; 53(3):61-77.
PMID: 28725297
PMC: 5501734.
DOI: 10.1016/j.jdsr.2016.11.001.
17β-Estradiol Inhibites Tumor Necrosis Factor-α Induced Apoptosis of Human Nucleus Pulposus Cells via the PI3K/Akt Pathway.
Wang T, Yang S, Liu S, Wang H, Liu H, Ding W
Med Sci Monit. 2016; 22:4312-4322.
PMID: 27847386
PMC: 5115218.
DOI: 10.12659/MSM.900310.
Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition.
Antoon J, Nitzchke A, Martin E, Rhodes L, Nam S, Wadsworth S
Int J Oncol. 2013; 42(4):1139-50.
PMID: 23403951
PMC: 3622654.
DOI: 10.3892/ijo.2013.1814.
Regulation of NF-κB activation through a novel PI-3K-independent and PKA/Akt-dependent pathway in human umbilical vein endothelial cells.
Balwani S, Chaudhuri R, Nandi D, Jaisankar P, Agrawal A, Ghosh B
PLoS One. 2012; 7(10):e46528.
PMID: 23071583
PMC: 3465347.
DOI: 10.1371/journal.pone.0046528.
Sublytic complement protects prostate cancer cells from tumour necrosis factor-α-induced cell death.
Liu L, Li W, Li Z, Kirschfink M
Clin Exp Immunol. 2012; 169(2):100-8.
PMID: 22774984
PMC: 3406369.
DOI: 10.1111/j.1365-2249.2012.04596.x.
Rapamycin increases oxidative stress response gene expression in adult stem cells.
Kofman A, McGraw M, Payne C
Aging (Albany NY). 2012; 4(4):279-89.
PMID: 22529334
PMC: 3371763.
DOI: 10.18632/aging.100451.
Distinct control of MyD88 adapter-dependent and Akt kinase-regulated responses by the interleukin (IL)-1RI co-receptor, TILRR.
Zhang X, Montagut Pino G, Shephard F, Kiss-Toth E, Qwarnstrom E
J Biol Chem. 2012; 287(15):12348-52.
PMID: 22262840
PMC: 3320984.
DOI: 10.1074/jbc.C111.321711.
Environmental signaling and reproduction: a comparative biological and chemical perspective.
McLachlan J, Tilghman S, Burow M, Bratton M
Mol Cell Endocrinol. 2011; 354(1-2):60-2.
PMID: 22178089
PMC: 3641892.
DOI: 10.1016/j.mce.2011.11.028.
Antioxidant c-FLIP inhibits Fas ligand-induced NF-kappaB activation in a phosphatidylinositol 3-kinase/Akt-dependent manner.
Iyer A, Azad N, Talbot S, Stehlik C, Lu B, Wang L
J Immunol. 2011; 187(6):3256-66.
PMID: 21856935
PMC: 3169770.
DOI: 10.4049/jimmunol.1002915.
Mechanisms of resistance to photodynamic therapy.
Casas A, Di Venosa G, Hasan T, Al Batlle
Curr Med Chem. 2011; 18(16):2486-515.
PMID: 21568910
PMC: 3780570.
DOI: 10.2174/092986711795843272.
Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2.
Antoon J, White M, Slaughter E, Driver J, Khalili H, Elliott S
Cancer Biol Ther. 2011; 11(7):678-89.
PMID: 21307639
PMC: 3084971.
DOI: 10.4161/cbt.11.7.14903.
Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: implications for breast cancer cell survival.
Bratton M, Duong B, Elliott S, Weldon C, Beckman B, McLachlan J
Int J Oncol. 2010; 37(3):541-50.
PMID: 20664923
PMC: 3613138.
DOI: 10.3892/ijo_00000703.
Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination.
Kassie F, Melkamu T, Endalew A, Upadhyaya P, Luo X, Hecht S
Carcinogenesis. 2010; 31(9):1634-41.
PMID: 20603442
PMC: 2930804.
DOI: 10.1093/carcin/bgq139.
Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines.
Somers-Edgar T, Taurin S, Larsen L, Chandramouli A, Nelson M, Rosengren R
Invest New Drugs. 2009; 29(1):87-97.
PMID: 19816657
DOI: 10.1007/s10637-009-9339-0.